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Background: Conflicting evidence exists regarding whether outcomes following coronary stenting are worse in women than in men.
Methods: Data on 426,996 patients ≥65 years old from the NCDR CathPCI Registry (2004-2008), including 42.3% women (n=180,752), were 
linked to Medicare inpatient claims. In-hospital and 30-month adjusted outcomes were compared by sex and stent type using Cox modeling that 
included propensity to receive drug-eluting stents (DES). Sex comparisons were performed with men as the reference; stent comparisons were 
performed using bare metal stents (BMS) as the comparison.
Results: Compared to men, women were significantly older and had greater comorbidities including hypertension, diabetes, and CHF, but less 
smoking, dyslipidemia, prior MI or CABG. Women had worse unadjusted and adjusted in-hospital complications following stenting than men 
including: death (adj OR 1.40, 1.32-1.48), MI (adj OR 1.19, 1.11-1.27), bleeding (adj OR 1.85, 1.78-1.93), and vascular (adj OR 1.85, 1.72-1.99) 
complications, all p<0.001. At 30 months women had lower adjusted risk of death (HR 0.92, 0.90-0.94), but similar rates of MI (HR 0.99, 0.95-
1.03), revascularization (HR 0.99, 0.97-1.02), and bleeding (HR 1.03, 0.98-1.09). Relative to BMS, use of DES were associated with almost identical 
improved long-term outcomes in women and men for: death (women: HR 0.78, 0.76-0.81; men: HR 0.77, 0.74-0.79), MI (women: HR 0.79,0.74-
0.84; men: HR 0.81, 0.77-0.85), and revascularization (women: HR 0.93, 0.90-0.97; men: HR 0.91, 0.88-0.94); however, no difference in bleeding 
(women: HR 0.96, 0.88-1.04; men: HR 0.94, 0.87-1.01) was observed between stent types for either sex. There was no significant interaction 
between sex and stent type for any long-term outcome. 
Conclusions: In contemporary PCI practice, women have slightly higher procedural risk than men, but have better long-term survival rates. Among 
both sexes, use of DES is associated with similarly lower risks for long-term death, MI, and revascularization.
